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Abbreviations
Alpha-SMA Alpha-smooth muscle actin
DP DegraPol®
ECM Extracellular Matrix
En Endotenon
H&E Hematoxylin-Eosin
i.v. Intra venous
PDGF-BB Platelet-derived growth factor-BB
RZ Reactive zone
SPF Specific pathogen free
Z Zone
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Abstract
Current methods for tendon rupture repair suffer from two main drawbacks: insufficient strength 
and adhesion formation, which lead to re-rupture and impaired gliding. A novel polymer tube may 
help to overcome these problems by allowing growth factor delivery to the wound site and 
adhesion reduction, and by acting as a physical barrier to the surrounding tissue. In this study, we 
used a bi-layered DegraPol® tube to deliver PDGF-BB to the wound site in a rabbit full 
transection Achilles tendon model. We then performed histological and immunohistochemical 
analysis at 3 weeks post-operation. Sustained delivery of PDGF-BB to the healing Achilles tendon 
led to a significantly more homogenous cell distribution within the healing tissue. Lower cell 
densities next to the implant material were determined for +PDGF-BB samples compared to –
PDGF-BB. PDGF-BB application increased proteoglycan content and reduced alpha-SMA+ areas, 
clusters of different sizes, mainly vessels. Finally, PDGF-BB reduced collagen I and III in the 
extracellular matrix. The sustained delivery of PDGF-BB via an electrospun DegraPol® tube 
accelerated tendon wound healing by causing a more uniform cell distribution with higher 
proteoglycan content and less fibrotic tissue. Moreover, the application of this growth factor 
reduced collagen III and alpha-SMA, indicating faster and less fibrotic tendon healing.
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Introduction
The healing of lacerated tendons is compromised by two main problems: re-rupture and adhesion 
formation [1]. An insufficiently strong scar tissue, lacking the aligned collagen organization seen 
in normal healthy tendons often leads to re-ruptures. The second drawback, adhesion formation 
between the regenerating tendon and the surrounding tissue, occurs in 7 to 15% of all cases, 
leading to a reduced range of motion, which ends up in higher work disability and costs [2,3]. To 
address these two problems, an elastic biodegradable polymer tube was developed in our research 
team [4]. It was tested for biocompatibility in vivo [4]. The polymer used was DegraPol® (DP) 
[5]. Furthermore, we synthesized a new more elastic polymer to make a reversible expandable DP 
tube which is surgeon-friendly and easily applicable in a clinical setting [6]. The performance of 
the electrospun tube acting as a physical barrier resulted in a 20 % reduction in adhesion formation 
when applied in a full transection rabbit Achilles tendon model [7]. Further development of the 
tube consisted in the incorporation of a growth factor, PDGF-BB, into the electrospun mesh by 
spinning an emulsion [8]. PDGF-BB enhances tendon healing with respect to accelerated 
mitogenesis, chemotaxis and vascularization [9].
In order to get insight into the effects of the released PDGF-BB from the electrospun tube 
implanted around a full transection rabbit Achilles tendon [10], we investigated the local 
distribution of tendon cells directly near the PDGF-BB delivery device, in proximity and further 
away from it. Such information may provide deeper insights into how migration of tendon cells to 
the healing tendon is influenced by this growth factor. Moreover, proteoglycan content to get 
information about the tendon’s affinity for adhesion [11] as well as alpha-SMA as a biomarker for 
fibrosis and scar formation [12] were determined. Finally, collagen I and III expression [13] was 
assessed to get insight into the state of healing progression.
Hence, the hypotheses of this histomorphometric study were
(i) PDGF-BB influences the total cell density and the cellular distribution in the healing 
tendon,
(ii) PDGF-BB increases the proteoglycan content in the healing tendon,
(iii) PDGF-BB reduces scar formation and
(iv) PDGF-BB accelerates the healing process. A
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Materials and Methods
PDGF-BB releasing DegraPol® tubes
Emulsion electrospun DP tubes with incorporated PDGF-BB were fabricated as reported 
previously [8]. In addition, DP tubes made by coaxial electrospinning to produce hollow fibers 
loaded with PDGF-BB [14] were produced as follows. Briefly, 10 wt % DP was used as a shell 
polymer solution, while 30 wt % polyethyleneglycol (PEG) solution with PDGF-BB, was used as 
a core polymer solution. The polymer solutions for the shell and core were delivered through two 
syringes mounted on two different syringe pumps (SP210cZ and Aladdin-1000, WPI, Germany) 
and different flow rates were used for each solution (shell: 1.5 mL h-1; core: 0.5 mL h-1). Voltage 
was 17 kV. The working distance between the spinneret and the collector was 18 cm. 
Electrospinning was performed at room temperature (22-24 °C) and less than 35 % humidity. 
Analogously fabricated tubes without PDGF-BB were used as controls. 
Animals
For this in vivo study, 12 female New Zealand White rabbits aged 12 to 16 weeks were used 
(Charles River, Research Models and Services, Germany). They were specific pathogen free 
(SPF). All animals were housed in pairs in two interconnected cages, each of them with a bottom 
area of 70 cm x 70 cm and a height of 62 cm (Indulab, Switzerland). The animals were maintained 
under controlled conditions: temperature 22 ± 1 °C, 45% relative humidity, 15 air changes per 
hour and a light/ dark rhythm of 12 hours. The rabbits had free access to water (automatic water 
supply), autoclaved hay and straw ad libitum and to standard pellet diet (Kliba Nafag, Nr. 3410, 
Provimi Kliba AG, Switzerland). Ethical approval for the experiments was obtained from the 
veterinary office of Zurich, Switzerland (reference numbers 92/ 2009 and 193/ 2012). Prior to 
surgery, all animals were acclimatized to their environment for 2 weeks.
Achilles tendon repair
The rabbits received premedication with 65 mg/ kg body weight Ketamine and 4 mg/ kg Xylazine 
[10]. A venous catheter was inserted in the marginal ear vein. The rabbits were intubated with 
Propofol i.v. 0.6-1.3 mg/ kg. Anaesthesia was maintained with 1-2% isofluorane. In order to 
ensure systemic analgesia during the time of operation, 0.2-0.3 mg/ kg body weight Butorphanol A
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(Dr. E. Graeub AG, Berne, Switzerland) was applied pre-operatively. The hind legs were shaved 
and cleaned with iodine (B.Braun Medical AG, Sempach, Switzerland). The Achilles tendon 
exposure was obtained through a paratendineal incision of cutis, subcutis and fascia. The medial 
and lateral M. gastrocnemius of the Achilles tendon complex were then sliced perpendicularly to 
the length of the tendon 2 cm above the calcaneus and one of the two fringed tendon stumps were 
sutured, while the fibre (USP 4.0 polypropylene) was then pulled through the DP tube (either with 
or without PDGF-BB loading), before the second tendon stump was sutured. The fibre was 
knotted in order to minimize the gap between the stumps. The DP tube was then flipped over the 
wound. Subsequently, the wound was closed with a running suture (using a USP 6.0 
polypropylene fibre) of the fascia and interrupted skin. Immediately post-surgery, a Durogesic 
Matrix patch (Janssen-Cilag AG, Switzerland) was applied with 4.2 mg Fentanyl per patch in 
order to provide analgesia for about 72 hours with 25 µg/ h Fentanyl. Postoperative treatment in-
cluded a cast having an angle of 180° at the ankle. The cast was well padded. Great attention was 
paid to make the casts not too tight so that it was tolerated well by the rabbits (they did not bite the 
cast). Three weeks post-surgery, the rabbits were euthanized in deep anaesthesia (100 mg/ kg 
Ketamine and 4 mg/ kg Xylazine) with 80 mg/ kg Pentobarbital (Esconarkon ad us. vet., 
Switzerland) and the tendons were extracted and stored at -20°C.
Treatment groups
The 12 rabbits were randomly distributed into 4 groups with n = 3 in each group. All were 
operated on one hind leg [15]. Of the operated legs, half were treated with an emulsion electrospun 
DegraPol® tube and half were treated with a coaxially electrospun DegraPol® tube, both with 
PDGF-BB incorporated in one layer, facing the tendon; the other half were also treated with the 
two differently electrospun tubes, but without PDGF-BB. The counter hind legs of all operated 
animals were not treated (NT) and served as control. For histological readouts, all Achilles 
tendons receiving a tube with PDGF-BB (merged 3 emulsion and 3 coaxial, n = 6) as well as all 
tendons receiving a tube without PDGF-BB (n = 6) were grouped. Moreover, all NT tendons were 
merged (n = 12).
Histological assessmentsA
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After being thawed to room temperature, the tendons were cut at the repaired site (perpendicular to 
the Achilles tendon). Longitudinal sections were taken (towards bone and towards muscle) and 
halved for different embedding procedures in a sagittal plane. The pieces for paraffin embedding 
procedure were fixed in formalin for 24 h, then dehydrated, paraffin-embedded and sectioned into 
5 µm thick slices. After deparaffinizing with xylene and rehydrating the sections, they were 
stained with Hematoxylin-Eosin (H&E), Hemalaun Sudan to stain the DegraPol® polymer reddish 
[16] and Alcian Blue according to commonly established procedures.
H&E stained paraffin sections were used to evaluate total cell density in five different zones (Z): 
in the endotenon (Z2), in a reference zone near the endotenon (Z3 En), in the zone directly 
adjacent to the DegraPol® (reactive zone Z4), and in a reference zone near the reactive zone (Z3 
RZ). In addition, to compare to most preferably healthy tissue, cell densities were also assessed in 
the core of the tendon (Z10), which was similar to native tendon tissue (not treated = NT). Alcian 
Blue stained paraffin sections were used to check whether sulphated proteoglycans were present. 
Zones were specified and numbered in accordance to a previous study [4].
The tendon pieces for cryogenic embedding were embedded in Tissue-Tek® O.C.T. (Sakura, 
Europe), then frozen and cryo-sectioned into 5 µm thick slices. After thawing, the sections were 
fixed with 4% paraformaldehyde for 10 minutes, then washed with 1xTBS and stained with H&E 
standard procedure. 
Dense tenocyte area ratios were determined in cryogenic section based on the definition that they 
had to lie between DegraPol® layers and be in the healing area; the dominating semi-quantitative 
scores for the selected FOV was then weighted in terms of how much (%) it is represented in the 
FOV, and the ratio defined as:
Ratio = score x % / 100 Equation (1).
For immunohistochemistry, paraffin embedded sections were deparaffinized with xylene and 
rehydrated, followed by an antigen retrieval step in 10 mM citrate buffer (pH 6.0) with 0.05 % 
Tween-20 for 20 min at 95 °C. If needed, depending of the epitope to stain, sections were 
permeabilized with 0.5 % Triton X-100 in 1xTBS for 10 min and subsequently washed 3 times 
with 1xTBS. Next, sections were blocked in 5 % donkey serum and 1 % BSA in 1xTBS for 1 hour A
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at room temperature. Afterwards, sections were incubated with mouse anti collagen I antibody 
(ab90395, Abcam, 1:200 dilution) or mouse anti collagen III antibody (AF5810, Acris, 1:200 
dilution) or mouse anti alpha-SMA antibody (A2547, Sigma-Aldrich, 1:500 dilution) diluted in 3 
% BSA in 1xTBS overnight at 4 °C. 
For one marker, fluorescent immunohistochemistry was performed (alpha-SMA), while for the 
others, chromogenic immunohistochemistry was performed (collagen I and III). For fluorescent 
immunohistochemistry, primary antibody solution was removed and samples were washed with 
1xTBS before incubation with secondary donkey anti-mouse Alexa-488 antibody (A-21202, 
Invitrogen, 1:500 dilution) and 10 µg/ mL 4’6-diamidino-2-phenylindole dilactate (DAPI) (Sigma-
Aldrich, Switzerland) diluted in 3% BSA in 1xTBS for 1 hour at room temperature. Afterwards, 
slides were washed in 1xTBS and mounted using Dako Fluorescence Mounting Medium 
(Agilent).
For chromogenic immunohistochemistry, the secondary antibody detection was performed using a 
biotinylated anti-mouse IgG secondary antibody and streptavidin-Horseradish peroxidase (HRP) 
(ZytoChem Plus HRP Kit Mouse, Zytomed Systems, Germany), followed by colorimetric 
detection using DAB substrate (DAB Substrate Kit High Contrast, Zytomed Systems, Germany) 
according to the manufacturer’s protocol. Afterwards, slides were washed in tap water and 
mounted using Faramount Aqueous Mounting Medium (Agilent).
Whole tissue sections were imaged on an automated slide scanner (Pannoramic 250 Flash II, 
3Dhistech, Budapest, Hungary) or photographed with a Leica 6000 light microscope. For 
quantitative analysis, cell nuclei were counted in selected Field Of Views (FOVs) (n = 5). Semi-
quantitative analysis was performed for proteoglycans, dense tenocyte area and alpha-SMA+ cells 
in selected FOVs (n = 5-15), examining the tissue quality with a previously established scoring 
scale (with 5 steps). For alpha-SMA intensity scores each FOV was sub-devided in 8 rectangles, 
totally 1116 score counts in 145 FOV, in 9 - 12 tendons per treatment group. From all evaluated 
values, each third value was used in order to avoid statistical overpowering. Structures like vessels 
were indexed by intensity and size and were counted in a predefined area. Definition: Small full 
clusters with circumference < 100 µm; precursor vessels < 100 µm; precursor vessels > 100 µm; A
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well developed vessels < 100 µm; well-developed vessels > 100 µm. For alpha-SMA-Cluster 
density, a total of 710 cluster counts in 145 FOV were analysed.
Statistical analysis
Data were analysed with StatView 5.0.1. One-way analysis of variance (one-way ANOVA) was 
conducted. Pairwise comparison probabilities (p) were calculated using the Bonferroni post hoc 
test. P values < 0.05 were considered significant (*). If p < 0.01, this was marked by **, and if 
p < 0.001 by ***. Values were expressed as means ± standard deviations if not otherwise stated.
Results
Total cell density in different zones
After extraction, treated tendon specimen were longer and had a higher cross-sectional area than 
NTs (SI Figure 2). Analysis of total cellular distribution (Figure 1) revealed similar cell densities 
in the native tendon tissue for both tendons (Z10; Figure 1A and SI Figure 1), treated with DP 
tubes loaded with or without PDGF-BB; both, however, had significantly higher cell densities than 
the contralateral not treated tendons (Figure 1B). While in the endotenon similar cell densities 
were observed (Figure 1C), significantly lower cell densities in PDGF-BB treated tendons were 
found in locations adjacent to the endotenon, here denoted as Z3 near endotenon (Figure 1D) and 
next to the implant material (Figure 1F) in the reactive zone Z4. These lower cell densities were at 
least partially compensated by higher cell densities close to DP in zone Z3 near DP (Figure 1E), 
covering wider areas than the zones Z3 near endotenon and Z4 reactive zone, respectively.
Dense tenocyte area ratio
A significantly different dense tenocyte area ratio was found for tendons treated with or without 
PDGF-BB (Figure 2). The growth factor led to a significantly higher dense tenocyte area ratio, 
showing more cell rich zones with mature tenocytes, compared to DP-treated tendons without 
PDGF-BB as well as compared to NT tendons.
Proteoglycan contentA
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Tendons that received a PDGF-BB treatment showed a significantly higher proteoglycan content 
as assessed by Alcian blue staining (Figure 3). Moreover, it was also significantly higher than in 
not treated tendons. In addition, tendons treated with tubes without PDGF-BB had a significantly 
higher proteoglycan content compared to NT tendons.
Alpha-SMA
Alpha-SMA expression was scored in immunohistochemically stained paraffin sections (Figure 
4). It was found that the delivery of PDGF-BB to the wound site reduced alpha-SMA expression 
significantly when compared to DP-treated tendons without growth factor. Moreover, both tube-
treated tendons (± PDGF-BB) had a significantly higher alpha-SMA expression compared to NT 
tendons (Figure 4A). Accordingly, the analysis of alpha-SMA in the different frame cluster types 
revealed significantly lower densities in case of PDGF-BB treatment compared to DP tube without 
PDGF-BB (Figure 4B); only the number of the smallest clusters, the precursor vessels < 100 µm 
and the well developed vessels > 100 µm did not differ between the treated groups; in addition, 
both groups showed always significantly higher alpha-SMA clusters compared to not treated 
tendons.
Collagen I and III
Collagen I and III were quantified in immunohistochemically stained longitudinal sections 
(Figure 5). The brown intensity in not treated tendons was twice as intense in Collagen I 
compared to Collagen III. For both, Collagen I and III, respectively, PDGF-BB treated tendons 
showed lower brown intensities as assessed by the red/ green ratio in the corresponding 
histograms. The presence of PDGF-BB reduced the collagen I intensity to around 88 % compared 
to PDGF-BB-free tendons; for collagen III, the corresponding value was 95 %. 
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Discussion
Background. PDGF-BB is a growth factor known to enhance mitogenesis, and it has been shown 
to support tendon healing [9]. We therefore designed a polymer tube with incorporated PDGF-BB 
[8] and assessed it in a full transected rabbit Achilles tendon model.In the present 
histomorphometric study, we examined the effects of PDGF-BB that was released from the inner 
bioactive layer of a bi-layered electrospun tube. Histomorphometry included analysis on a cellular 
and extracellular matrix level, considering cell migration and resulting distributions as well as 
proteoglycans, collagen types I and III and alpha-SMA. The rather early time point post-operation 
(three weeks) was chosen based on the release kinetics of PDGF-BB from the polymer tube in 
vitro [8], which revealed more than 90 % of the diffusible PDGF-BB released at day 21.
Main findings. PDGF-BB promoted tendon healing by decreasing cell densities near the implant 
surface and near the endotenons, ending up in a more homogenous cell density at the repair site 
(Figure 1). Moreover, PDGF-BB treated specimen showed a significantly higher proteoglycan 
content (Figure 3), while alpha-SMA (Figure 4), a marker of smooth muscle cells as well as 
myofibroblasts, and collagen III (Figure 5), a transient type of collagen during tendon healing, 
were significantly lower when compared to tendons treated with tubes without PDGF-BB.
Proliferation and migration. It is well known that PDGF-BB enhances proliferation of 
fibroblasts [17-19]. In addition, PDGF-BB acts via chemotaxis and has an influence on the cell 
migration. It has been shown that a porcine cross-linked collagen sponge from Geistlich® Pharma 
seeded with human gingival fibroblasts and either treated or not with PDGF-BB increased the 
distance of the fibroblasts to the margin of the scaffold. In other words, PDGF-BB enhanced the 
migration into the porous material and led to a more homogenous cell distribution within the 
sponge [20]. Accordingly, we found that the tenocyte and tenoblast density was significantly 
lowered directly next to the tube implant (Figure 1F, zone Z4) and also near the endotenons 
(Figure 1D, Z3 near EN). Correspondingly, the zones located further away from the implant as 
well as from the endotenon, were populated with a significantly higher cell density (Figure 1E, Z3 
near DP). The cells apparently migrate from the vicinity of the implant and endotenons towards 
more distanced places; to sites between the PDGF-BB secreting implant and the tenoblast-rich 
endotenon. This results in an overall more homogenous cell distribution at the wound site. The A
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healing process is therefore accelerated by PDGF-BB: after a cellular and proliferative phase, cell 
density at the wound site declines to pave the way for the remodeling phase [21].
Nevertheless, we determined that dense tenocyte area ratios of mature tenocytes (and not 
tenoblasts) were found in higher numbers in the presence of PDGF-BB compared to tendons 
treated without PDGF-BB (Figure 2). They were situated directly at the wound site where the 
proper tendon had been cut by a scalpel during surgery. To our knowledge, such clusters of mature 
tenocytes have not been reported previously. It might be speculated that they are formed under the 
influence of PDGF-BB that, on the one hand leads to more homogenous cell distribution of all 
types of cells, however, that on the other hand leads to an advanced maturation of the tenoblasts, 
resulting in clusters of mature tenocytes. From the maturity point of view, such tenocyte clusters 
attest an accelerated healing; from the cluster point of view, however, it rather puts proper healing 
into question.
Proteoglycans. PDGF-BB treated tendons showed significantly higher contents of proteoglycans 
compared to their PDGF-BB-free analogous (Figure 3). This was expected and stands in 
accordance with other studies. The growth factor PDGF-BB has been shown to increase the 
proteoglycan content in rabbit tendons in a dose-dependent manner; for intermediate and proximal 
intrasynovial flexor tendon segments an effective concentration lied in the range of 0.1-30 and 0.1-
100 ng/ mL PDGF-BB, respectively [22]. Up to six weeks post-laceration, glycosaminoglycan 
(GAG) content and accordingly proteoglycans are elevated in healing tendons [21]. It may be 
speculated that a higher proteoglycan content at three weeks is attributed to an earlier GAG-peak, 
meaning that the whole healing process has been accelerated and certain stages – here maximum 
proteoglycan content – reached at earlier time point post-surgery.
Alpha-SMA. In contrast to fetal tendons, the healing default pathway of adult tendons is the 
formation of fibrovascular scar [23]. One central marker of fibrotic tissue and fibrosis in general is 
alpha-SMA. Here, we clearly found that PDGF-BB released from our tube implant reduced the 
alpha-SMA+ cells in the healing Achilles tendons (Figure 4). First, the general alpha-SMA level 
in immunohistochemically stained sections was significantly lower; this included not only 
myofibroblasts [24,25], a transient cell type during tendon healing, but also vascular smooth 
muscle cells [26]. Second, the semi-quantitatively scored alpha-SMA+ clusters of various size, A
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which are mainly attributed to vessels, were also significantly lower in the PDGF-BB samples 
(except for the small clusters sized < 100 µm,  which were similar and the precursor vessels < 100 
µm and the well developed vessels > 100 µm which were lower, but not significantly lower). 
These findings are supported by a study from Comut and co-workers who found a decreased 
alpha-SMA protein synthesis in human gingival fibroblasts in the presence of 10 ng/ mL PDGF-
BB [27]. Interestingly, the same study revealed a correlation between the fibroblast orientation and 
the alpha-SMA synthesis of the cells, which we were, however, not able to detect in our 
experimental setting. In contrast, another research group found no effect of PDGF-BB (10 ng/ mL) 
on alpha-SMA expressing cells in the torn human rotator cuff [28]. Nevertheless, it was noted that 
alpha-SMA containing cells could contribute adversely to the healing of the rotator cuff, by 
retraction of the torn ends.
A reduced alpha-SMA protein amount in the presence of PDGF-BB can be judged positively 
because it is attributed to less scar formation during the healing process. For example, 
hypertrophic scar fibroblasts co-cultured with ASCs and receiving their secretome with many 
cytokines and trophic factors had a lower gene expression in alpha-SMA compared to their 
monoculture [12]. Although not primarily PDGF-BB was applied to these hypertrophic scar 
fibroblasts, but a cocktail of many factors, this still supports our finding of lower alpha-SMA 
expression as a positive, anti-fibrotic outcome. In addition, the lower densities of vessel-like 
structures that were alpha-SMA+ (smooth muscle cells) can be interpreted as a progression during 
tendon healing where angiogenesis and vascularization are mainly occurring immediately after the 
tendon rupture and decline overtime [21]. As such, lower vessel densities 3 weeks post-laceration 
imply an advanced state in the healing process.
Collagen. The main type of collagen found in native healthy tendons is collagen I. During tendon 
healing, collagen type III is built up transiently and is finally replaced by collagen I at later stages 
[21]. Here, we found that at three weeks post-surgery, the collagen III content was significantly 
lower in the case of PDGF-BB treatment (Figure 5). This might be associated with a faster tendon 
healing [29]; in other words, the maximum of collagen III increase might have already been over 
during the healing, indicating a progressed stage.
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John 
Wiley & Sons Ltd.  
We also found a lower collagen I content for PDGF-BB treated tendons, standing in contrast to 
other PDGF-BB studies where the growth factor stimulated collagen I production [30-32]. Our 
findings of lower collagen I implies that other extracellular matrix (ECM) components – like 
proteoglycans that were significantly increased by PDGF-BB (Figure 3) – reduced the relative 
amount of collagen I, ending up in a lower staining intensity.
Limitations. Although we present a comprehensive histomorphometric analysis of the healing 
tendon tissue in the presence of a sustained PDGF-BB delivery from an electrospun tube, there are 
several limitations to this study. First, biomechanical properties of the tendons would be 
interesting to assess. Second, longer time points post-surgery, but also shorter time points than 3 
weeks would help to elucidate the mechanism of PDGF-BB. Last, adhesion extent of the healing 
tendon to the surrounding tissue in the presence and absence of PDGF-BB would be a further 
interesting topic to address. For this, sample processing would be different than in this study 
presented here, with more cross-sectional sections rather than longitudinal ones.
 
Summary and conclusion. The sustained delivery of PDGF-BB to a fully transected Achilles 
tendon had positive effects with respect to the cellular and ECM healing pattern. It reduced 
fibrotic markers like alpha-SMA, accelerated the healing as indicted by a lower collagen III 
intensity and finally led to a more homogenously distributed cellular density.  Thus, providing 
PDGF-BB in a controlled sustained manner to the wound site is promising with regard to tendon 
rupture repair and might find its way into clinical practice.
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Figure Captions
Figure 1 Total cell densities in different zones 3 weeks post-surgery. Overview of zones in a 
Hemalaun-Sudan stained section, length of scale bar = 100 µm (A); total cell density in Z10 native 
core tissue (B); Z2 cells in the endotenon (C); zone Z3 lying near an endotenon (D); Z3 near DP 
(E) and Z4 reactive zone next to DP (F). Values are given as means ± standard error. The numbers 
for the zones (Z2, Z3, Z4 and Z10, respectively), were used in accordance with previously 
published work [4]. One-way ANOVA was performed. P values < 0.05 were considered 
significant (*). If p < 0.01, this was marked by **, and if p < 0.001 by ***. Error bars indicate 
standard deviations. Biological independent replicates n = 6. An overview of the whole 
longitudinal section is provided in SI Figure 1.
Figure 2 Dense tenocyte area ratio determined for PDGF-BB release electrospun meshes three 
weeks post-operation. Semi-quantitative scores were defined according to the density of tenocyte 
rich areas in cryogenic sections, stained with H&E. Additional images for scores 1-5 can be found 
in SI Figure 3. Moreover, the percentage of these areas in 15 FOVs per tendon was determined. 
The ratio was calculated according to: Ratio = score x % / 100. Note: for determination of the 
ratio, the zones with mainly mature tenocytes (with a slender spindle-shaped morphology) have 
been considered. One-way ANOVA was performed.  P values < 0.05 were considered 
significant (*). If p < 0.01, this was marked by **, and if p < 0.001 by ***. Error bars indicate 
standard deviations. Biological independent replicates n = 6. Scale bars = 50 µm.
Figure 3 Proteoglycan content determined for PDGF-BB release from full transection Achilles 
tendons: definition of scores by typical fields of view in Alcian Blue stained paraffin sections 
(scores 1-5 above, scale bar = 100 µm) and semi-quantitative determination (below). One-way 
ANOVA was performed.  P values < 0.05 were considered significant (*). If p < 0.01, this was 
marked by **, and if p < 0.001 by ***. Error bars indicate standard deviations. Biological 
independent replicates n = 6. Additional images for scores 1-5 can be found in SI Figure 4.
Figure 4 Alpha-SMA+ cells. Semi-quantitative scoring system: 1 to 5 definition (A top row), 
analyzed in 5 FOVs, each FOV with 8 rectangles (A bottom left); Cluster densities: visualization 
of cluster categories (B top row) and mean densities (B bottom row) of the corresponding cluster A
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type. Cluster categories (from left to right): Small full clusters with circumference < 100 µm; 
precursor vessels < 100 µm; precursor vessels > 100 µm; well developed vessels < 100 µm; well 
developed vessels > 100 µm. Legend: DP = DegraPol®, GF = PDGF-BB, NT = not treated. One-
way ANOVA was performed.  P values < 0.05 were considered significant (*). If p < 0.01, this 
was marked by **, and if p < 0.001 by ***. Error bars indicate standard deviations. Biological 
independent replicates n = 6. Scale bars in A = 100 µm; in B = 50 µm. Additional images for 
scores 1-5 can be found in SI Figure 5A; and for different cluster size in SI Figure 5B.
Figure 5 Collagen I and III immunohistochemistry of Achilles tendons in paraffin sections, 
with red/ green ratio to assess brown staining intensity and typical examples for tendons stained 
with Collagen I and III. One-way ANOVA was performed.  P values < 0.05 were considered 
significant (*). If p < 0.01, this was marked by **, and if p < 0.001 by ***. Error bars indicate 
standard deviations. Biological independent replicates n = 6. Scale bars = 1000 µm. Positive (NT) 
and negative (rabbit brain) controls for collagen I and III staining are given in SI Figure 6.
Supporting Documents
SI Figure 1 Overview of  typical longitudinal sections. A tendon that received a DP tube after 
surgical repair. Magnification: 8x. Haemalaun Sudan staining (left) and Picosirius Red staining 
(right). Areas A and B (the small green rectangles) are magnified below. 
SI Figure 2 Macroscopic images. Macroscopic images of the healing tendons three weeks post-
surgery. Based on NT (no treatment) tendons as reference, the cross-sectional area of the treated 
tendons increased; it was 248 ± 59 % (tube without PDGF-BB) and 211 ± 62 % (tube with PDGF-
BB) relative to NT (100 ± 18 %). The length of the treated tendons also increased compared to 
NTs: 135 ± 11 % (tube without PDGF-BB) and 110 ± 20 % (tube with PDGF-BB) relative to NT 
(100 ± 19 %).
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SI Figure 3 Scoring system for tenocyte rich areas. Examples for semi-quantitative scores with 
different densities of tenocyte rich areas. This is additional information to Figure 2 in the main 
manuscript.
SI Figure 4 Scoring system for proteoglycans. Examples for semi-quantitative scores with 
different Alcian blue intensities referring to different proteoglycan content. This is additional 
information to Figure 3 in the main manuscript.
SI Figure 5 Scoring system for alpha-SMA. Representative images for semi-quantitative scores 
with different amounts of alpha-SMA+ cells (A). Examples for clusters (B) with categories (from 
top to down row): small full clusters with circumference < 100 µm; precursor vessels < 100 µm; 
precursor vessels > 100 µm; well developed vessels < 100 µm; well developed vessels > 100 µm.  
This is additional information to Figure 4A and 4B, respectively, in the main manuscript.
SI Figure 6 Positive and negative controls for collagen I and collagen III staining. Native 
rabbit tendons were used as positive control (top) and native rabbit brain tissue was used as 
negative control. 
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